Drug – bio-affecting and body treating compositions – Designated organic nonactive ingredient containing other... – Carboxylic acid or salt thereof
Patent
1994-05-05
1998-04-21
Cintins, Marianne M.
Drug, bio-affecting and body treating compositions
Designated organic nonactive ingredient containing other...
Carboxylic acid or salt thereof
514786, 514558, 514560, A61K 4700
Patent
active
057418225
ABSTRACT:
A composition is disclosed containing non-esterified fatty acids having 14-18 carbon atoms, monoglycerides which are monoesters of glycerol and fatty acids having 14-18 carbon atoms, lysophosphatidylcholine in which the fatty acid moiety has 14-18 carbon atoms and bicarbonate. The compositions can optionally also contain bile salts. These compositions form submicron size colloidal particles and can act as vehicles for transporting orally administered drugs, sources of calories in the form of readily absorbable fats and as particles for topical application to the skin. A method of making these particles is also described.
REFERENCES:
patent: 3169094 (1965-02-01), Wretlind
patent: 4035513 (1977-07-01), Kumano
patent: 4156719 (1979-05-01), Sezaki et al.
patent: 4280996 (1981-07-01), Okamoto et al.
patent: 4325942 (1982-04-01), Taki et al.
patent: 4454113 (1984-06-01), Hemker
patent: 4464400 (1984-08-01), Kimura et al.
patent: 4874795 (1989-10-01), Yesair
Muranishi, S. et al., "Improvements of Absolute BioavailabilIty of Normally Poorly Absorbed Drugs: Inducement of the Intestinal Absorption of Streptomycin and Gentamycin by Lipid-Bile Salt Mixed Micelles in . . . " Int'l J. Pharmaceutics 2: 101-111 (1979).
Muranishi, S. et al., "Absorption of 5-Fluorouracil from Various Regions of Gastrointestinal Tract in Rat. Effect of Mixed Micelles" J. Pharm Dyn. 2: 286-294 (1979).
Muranushi, N. et al., "Mechanism for the Inducement of the Intestinal Absorption of Poorly Absorbed Drugs by Mixed Micelles I. Effects of Various Lipid-Bile Salt Mixed Micelles . . . " Int'l J. Pharmaceutics 4: 271-279 (1980).
Taniguchi, K. et al., "Enhanced Intestinal Permeability to Macromolecules II. Improvement of the Large Intestinal Absorption of Heparin by Lipid-Surfactant Mixed Micelles in Rat" Int'l J. of Pharamaceutics 4: 219-228 (1980).
Serajuddin, A.T.M. et al., "In Situ Intestinal Absorption of a Poorly Water-Soluble Drug From Mixed Micellar Solutions of Bile Salt and Lipolysis Products in Rats" Pharmaceut. Res. (Received: Oct. 11, 1984; Accepted: Apr. 2, 1985) 221-224.
Yoshikawa, H. et al., "Potentiation of Enteral Absorption of Human Interferon Alpha and Selective Transfer into Lymphatics in Rats" Pharmaceut. Res. (Received: Jan. 25, 1985; Accepted: May 6, 1985) 249-250.
Muranishi, S., "Modification of Intestinal Absorption of Drugs by Lipoidal Adjuvants" Pharmaceut. Res. (1985) pp. 108-118.
Chem. Abst., 102: 154829p (1985) Ohashi et al.
Tso, P. et al. "The Importance of the Lysophosphatidylcholine and Choline Moiety of Bile Phosphatidylcholine in Lymphatic Transport of Rat" Biochimica et Biophysics Acta, 528: 364-372 (1978).
Tso, P. et al., "Formation and Transport of Chylomicrons by Enterocytes to the Lymphatics," Am. J. Physiol. 250 (6 Pt 1), 715-726 (Jun. 1986). Abstract only.
Staggers, J.E., "Lipid Digestion and Absorption in the Suckling Rat," Dissertation Abstracts International, (Sciences and Engineering), 44(10) : 3069 (218 pp) (1984). Abstract only.
Cintins Marianne M.
Moezie M.
LandOfFree
Mixed lipid-bicarbonate colloidal particles for delivering drugs does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Mixed lipid-bicarbonate colloidal particles for delivering drugs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mixed lipid-bicarbonate colloidal particles for delivering drugs will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2057901